A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 15 Apr 2016
At a glance
- Drugs Fasiglifam; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 Feb 2012 Results published in The Lancet, according to a Takeda media release.
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 29 Jun 2011 Results were presented at the 71st Annual Scientific Sessions of the American Diabetes Association (ADA), according to a Takeda media release.